Scribe Therapeutics Inc.
NASDAQ:SCTXBiotechnology
-$0.91 today
- Market cap
- $255.19M
- Beta
- 0.00
Volume 0.27M
Average 0.98M
Price history
Scribe Therapeutics Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+5.13%
Period high
$37.25
Period low
$15.00
Latest
$15.77
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 8-K | Nov 12, 2026 | Nov 12, 2026 | |
| 10-Q | Nov 12, 2026 | Nov 12, 2026 | |
| 10-Q | Sep 2, 2026 | Sep 2, 2026 | |
| 8-K | Sep 2, 2026 | Sep 2, 2026 | |
| SC 13G | Aug 3, 2026 | Aug 3, 2026 | |
| SC 13D | Jul 30, 2026 | Jul 30, 2026 | |
| SC 13D | Jul 30, 2026 | Jul 30, 2026 | |
| 4 | Jul 29, 2026 | Jul 29, 2026 | |
| 4 | Jul 29, 2026 | Jul 29, 2026 | |
| SC 13D | Jul 29, 2026 | Jul 29, 2026 | |
| 4 | Jul 29, 2026 | Jul 29, 2026 | |
| 4 | Jul 29, 2026 | Jul 29, 2026 | |
| 4 | Jul 28, 2026 | Jul 28, 2026 | |
| 4 | Jul 28, 2026 | Jul 28, 2026 | |
| 4 | Jul 27, 2026 | Jul 27, 2026 |
Competitors
Who does Scribe Therapeutics Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
No competitor data available.
Questions
Filing questions
Common questions about SCTX's filings, answered from its disclosures.
What is the latest SCTX filing?
The latest filing shown is 8-K dated Nov 12, 2026.
How many recent filings does SCTX have?
Intrinsic Alpha currently shows 20 recent filings for SCTX.
Continue the stock analysis
Jump to another research area for this company.